Altay Biopharma
Altay Biopharma, also known as Altay Therapeutics, is a company that is developing a novel small molecule inhibitor (ALT-CP4) for fibrosis, which targets a cellular protein that regulates matrix deposition and immune activation.
Overview
Altay Biopharma, also known as Altay Therapeutics, is a company that is developing a novel small molecule inhibitor (ALT-CP4) for fibrosis, which targets a cellular protein that regulates matrix deposition and immune activation.
| Name | Phone | Social networks | |
|---|---|---|---|
| Al* Oz** | - | - | |
| Os*** Oz** | - | - |
Industries
Altay Biopharma is active in the following industries:
- Therapeutics
- Biopharmaceutical
- Blockchain
- Technology
- Biotechnology
- Biology
- Blockchain and cryptocurrency